Skip to content
Open access

4-Diketopyrrole-2-carboxamide derivatives affecting HBV capsid assembly: structure–activity relationship around the GLP-26 scaffold

Oct 2026 · Organic and biomolecular chemistry · Vol 24, pp. 8323 - 8338 · 0 citations
Medicine

TL;DR

The structure–activity relationship (SAR) around the 4-diketopyrrole-2-carboxamide scaffold of GLP-26 is discussed, focusing on modifying the aniline moiety and the oxoacetamide region, and introducing alternative acetamide groups.

Abstract

Chronic hepatitis B virus (HBV) infection remains a major global health burden with limited curative options. Capsid assembly modulators (CAMs) have emerged as a promising antiviral strategy by disrupting nucleocapsid formation and suppressing cccDNA amplification. In this study, we discuss the structure–activity relationship (SAR) around the 4-diketopyrrole-2-carboxamide scaffold of GLP-26, focusing on modifying the aniline moiety and the oxoacetamide region, and introducing alternative acetamide groups. Compounds were synthesized through efficient coupling strategies, including microwave-assisted amidation, and several analogs exhibited potent inhibition of HBV DNA replication in HepAD38 cells, with EC50 values in the low nanomolar range and minimal cytotoxicity. This work broadens the chemical space surrounding GLP-26 and provides a valuable roadmap for designing new scaffolds for next-generation HBV CAMs.

Read PDF

Similar papers

#protein folding Sep 2026

Integrated AI-Driven Multi-Objective Optimization of Sulfamoylbenzamide-Based HBV Capsid Assembly Modulators: Discovery of 11B-6 with Superior Potency and Drug-like Properties

A multi-objective optimization workflow for the NVR 3-778 is reported by integrating structure-based fragment growing with systematic medicinal chemistry optimization, activity prediction, and multitask prediction of drug-like properties to highlight 11B-6 as a promising next-generation HBV CAM.

Shuo Wang, Miao-Chen Xu, Fei-Yue Ma et al. · 0 citations
Review Sep 2026

Structure-guided discovery of HIV-1 capsid inhibitors: From diverse binding sites to resistance-resilient antiviral strategies.

This review covers 2020-2026 advances in CA-targeted drug discovery: high-resolution CA structures; allosteric regulation by host metabolite IP6; medicinal chemistry optimization of PF74 derivatives via scaffold hopping and conformational restriction to enhance potency and metabolic stability; the development and clini...

Yu-Ya Li, Mei Wang, Lin Sun et al. · 0 citations
Open access Oct 2026

Evaluation of 6-substituted coumarins as SARS-CoV-2 main protease inhibitors: enzymatic, cellular, and computational insights

The SARS-CoV-2 main protease (Mpro) plays a crucial role in viral replication, making it an attractive target for antiviral drug development. This study evaluates the inhibitory potential of nineteen 6-substituted coumarin derivatives (1a–p and 2a–c) against Mpro using a FRET-based enzymatic assay. Among them, the chlo...

Ashraf K. El-Damasy, Md Sofequl Islam Mukim, Sangeun Jeon et al. · 0 citations
Open access Oct 2026

Discovery of dihydrothiazolo ring-fused 2-pyridones with extended carboxylic acid as anti-influenza A agents.

The identification of a series of dihydrothiazolo-ring-fused 2-pyridones bearing an extended carboxylic acid motif as promising antiviral scaffolds are reported, establishing the extended carboxylic-acid 2-pyridone scaffold as a strong foundation for advancing both targeted anti-influenza A agents and broader-spectrum...

Samuel A. Nyantakyi, Md. Koushikul Islam, Urban Fagerholm et al. · 0 citations
Review Open access Aug 2026

1,2-Benzothiazine Derivatives as Anti-HIV and Anti-HCV Agents: Structure–Activity Relationships and Research Perspectives

Despite showing antiviral activity against both HIV and HCV, all tested compounds, including the most active derivatives, were considerably less potent than the corresponding reference drugs.

Izabela Topolska, B. Szczęśniak-Sięga · 0 citations
Sep 2026

Synthesis of Novel Pyrazolopyranopyrimidine Acyclic Nucleosides Disubstituted at N2/C5 as Potential Anti-SARS-CoV-2 Inhibitors: Structural Characterization, and In Silico Studies

Novel pyrazolo[4′,3′:5,6]pyrano[2,3-d]pyrimidine acyclonucleosides bearing HBG-derived pseudosugar moieties bearing HBG-derived pseudosugar moieties as potential antiviral agents targeting key SARS-CoV-2 proteins are designed and synthesized.

Ezaddine Irrou, Younesse Ait Elmachkouri, Rakibul Islam et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.